QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST)

SEK 0.02

(0.0%)

Market Cap (In SEK)

26.81 Million

Revenue (In SEK)

4.37 Million

Net Income (In SEK)

-16.52 Million

Avg. Volume

2.77 Million

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.012-0.145
PE
-
EPS
-
Beta Value
0.439
ISIN
SE0020678159
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Marcus Bosson
Employee Count
-
Website
https://www.quiapeg.com
Ipo Date
2005-06-21
Details
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.